Items where authors include "Falk, S."

Article

Mukherjee, S., Qi, C., Shaw, R. et al. (20 more authors) (2024) Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial. European Journal of Cancer, 209. 114236. ISSN 0959-8049

Group, F.C., Glasbey, J., Beggs, A. et al. (430 more authors) (2024) Risk of Bowel Obstruction in Patients Undergoing Neoadjuvant Chemotherapy for High-risk Colon Cancer. Annals of Surgery, 280 (2). pp. 283-293. ISSN 0003-4932

Rosan, T.M., Sitch, S., O'Sullivan, M. et al. (36 more authors) (2024) Synthesis of the land carbon fluxes of the Amazon region between 2010 and 2020. Communications Earth & Environment, 5. 46. ISSN 2662-4435

Rosan, T.M., Sitch, S., O’Sullivan, M. et al. (36 more authors) (2024) Synthesis of the land carbon fluxes of the Amazon region between 2010 and 2020. Communications Earth & Environment, 5 (46). ISSN 2662-4435

Corrie, P.G., Qian, W., Basu, B. et al. (31 more authors) (2020) Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma. British Journal of Cancer, 122 (12). pp. 1760-1768. ISSN 0007-0920

Sebag-Montefiore, D. orcid.org/0000-0002-5978-9259, Adams, R., Gollins, S. et al. (17 more authors) (2020) ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC). Journal of Clinical Oncology, 38 (15_suppl). 4101. ISSN 0732-183X

Lee, S.M., Upadhyay, S., Lewanski, C. et al. (11 more authors) (2019) The clinical role of VeriStrat testing in patients with advanced non–small cell lung cancer considered unfit for first-line platinum-based chemotherapy. European Journal of Cancer, 120. pp. 86-96. ISSN 0959-8049

Neoptolemos, J.P., Palmer, D.H., Ghaneh, P. et al. (32 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389 (10073). pp. 1011-1024. ISSN 0140-6736

Haslett, K., Franks, K., Hanna, G.G. et al. (12 more authors) (2016) Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study. BMJ Open, 6 (4). e010457. e010457-e010457. ISSN 2044-6055

Schuch, B., Feigenbutz, M., Makino, D.L. et al. (4 more authors) (2014) The exosome-binding factors Rrp6 and Rrp47 form a composite surface for recruiting the Mtr4 helicase. EMBO Journal, 33 (23). 2829 - 2846. ISSN 0261-4189

Minett, M.S., Falk, S., Santana-Varela, S. et al. (4 more authors) (2014) Pain without Nociceptors? Nav1.7-Independent Pain Mechanisms. Cell Reports, 6 (2). pp. 301-312.

Proceedings Paper

Mukherjee, S., Hurt, C., Cox, C. et al. (17 more authors) (2020) Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial. In: Journal of Clinical Oncology. 2020 Gastrointestinal Cancers Symposium, 23-25 Jan 2020, San Francisco, CA, USA. American Society of Clinical Oncology , p. 373.